Insider Trading activities of Pacira Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pacira Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pacira Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Pacira Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is PCRX. The reporting company's CIK number is 1396814.
The total value of stock buying since 2005 is $44,653,659.
The total value of stock sales since 2005 is $300,009,319.
The total value of stock option exercises since 2005 is $4,036,149.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pacira Pharmaceuticals, Inc. (PCRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 100 $3,713 33,390 $1,215,478 28,885 $46,504
2017-07 0 $0 0 $0 15,000 $24,150
2017-06 0 $0 11,409 $495,420 15,000 $24,150
2017-05 0 $0 41,041 $2,094,145 41,041 $324,270
2017-01 0 $0 35,000 $1,352,450 35,000 $153,350
2016-11 0 $0 35,000 $1,292,275 35,000 $114,550
2016-10 0 $0 0 $0 30,000 $48,300
2016-08 0 $0 40,000 $1,810,050 40,000 $122,600
2016-06 0 $0 4,574 $215,563 0 $0
2016-04 0 $0 25,000 $1,607,375 25,000 $137,250
2016-02 0 $0 3,000 $180,000 3,000 $37,185
2016-01 3,800 $235,054 15,000 $953,505 15,000 $24,150
2015-11 0 $0 3,000 $180,000 3,000 $32,430
2015-10 0 $0 15,000 $567,450 15,000 $24,150
2015-09 5,000 $306,850 0 $0 0 $0
2015-08 0 $0 3,000 $180,060 3,000 $32,430
2015-07 0 $0 15,000 $1,016,700 15,000 $24,150
2015-04 0 $0 27,500 $2,482,475 27,500 $75,200
2015-03 1,000 $93,830 8,000 $762,540 16,349 $187,236
2015-02 0 $0 15,000 $1,673,130 15,000 $24,150
2015-01 0 $0 17,500 $1,703,905 17,500 $59,100
2014-12 2,645 $250,058 1,000 $93,320 1,000 $29,900
2014-11 1,080 $96,830 15,000 $1,321,980 15,000 $24,150
2014-10 0 $0 17,500 $1,720,345 17,500 $59,100
2014-09 0 $0 1,000 $96,400 1,000 $29,900
2014-08 0 $0 262,307 $27,038,895 35,000 $172,110
2014-07 0 $0 47,200 $4,109,938 47,500 $238,200
2014-06 0 $0 204,900 $17,009,132 1,000 $29,900
2014-05 0 $0 216,000 $16,403,822 80,000 $314,250
2014-03 0 $0 25,887 $2,059,530 1,000 $29,900
2013-12 0 $0 27,500 $1,531,930 27,500 $44,275
2013-11 0 $0 50,000 $2,600,850 50,000 $540,500
2013-10 0 $0 20,000 $978,400 20,000 $32,200
2013-09 1,000 $37,010 55,283 $2,425,866 37,500 $99,175
2013-08 0 $0 14,700 $543,900 14,700 $23,667
2013-07 0 $0 458,223 $14,592,623 69,754 $112,303
2013-06 0 $0 510,054 $15,068,630 66,375 $448,201
2013-05 853 $24,992 329,313 $10,148,651 0 $0
2013-04 0 $0 231,166 $6,879,031 40,000 $64,400
2013-03 0 $0 5,070,886 $141,972,573 46,375 $228,713
2013-01 0 $0 500,000 $9,465,000 0 $0
2012-04 10,000 $97,500 0 $0 0 $0
2012-03 0 $0 100,100 $1,112,221 0 $0
2012-02 1,607,142 $11,249,994 185,400 $2,028,098 0 $0
2011-11 2,017,690 $13,114,985 0 $0 0 $0
2011-10 0 $0 97,441 $1,025,663 0 $0
2011-02 2,734,949 $19,142,843 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Pacira Pharmaceuticals, Inc. insiders (PCRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-22 Hastings Paul J (Director) Sale 1,044 36.15 37,740
2017-08-15 Williams Kristen Marie (CAO and General Counsel) Sale 3,461 36.75 127,191
2017-08-15 Stack David M (CEO and Chairman) Sale 28,885 36.37 1,050,547
2017-08-15 Stack David M (CEO and Chairman) Option Ex 28,885 1.61 46,504
2017-08-08 Froimson Mark (Director) Buy 100 37.13 3,713
2017-07-24 Stack David M (CEO and Chairman) Option Ex 15,000 1.61 24,150
2017-06-23 Stack David M (CEO and Chairman) Option Ex 15,000 1.61 24,150
2017-06-07 Riker Lauren Bullaro (Vice President, Finance) Sale 1,119 44.37 49,650
2017-06-05 Jones James B (SVP & Chief Medical Officer) Sale 767 43.32 33,227
2017-06-05 Braunstein Scott (SVP, Strategy & Corp. Dev.) Sale 768 43.32 33,270
2017-06-05 Riker Lauren Bullaro (Vice President, Finance) Sale 601 43.32 26,035
2017-06-05 Scibetta James S (President) Sale 1,966 43.32 85,169
2017-06-05 Williams Kristen Marie (CAO and General Counsel) Sale 1,877 43.32 81,313
2017-06-05 Stack David M (CEO and Chairman) Sale 4,311 43.32 186,756
2017-05-15 Scibetta James S (President) Sale 20,000 51.20 1,024,000
2017-05-15 Scibetta James S (President) Option Ex 20,000 5.49 109,800
2017-05-15 Williams Kristen Marie (CAO and General Counsel) Sale 21,041 50.86 1,070,145
2017-05-15 Williams Kristen Marie (CAO and General Counsel) Option Ex 21,041 10.19 214,470
2017-01-17 Scibetta James S (President) Sale 20,000 38.68 773,600
2017-01-17 Scibetta James S (President) Option Ex 20,000 3.55 71,000
2017-01-17 Stack David M (CEO and Chairman) Sale 15,000 38.59 578,850
2017-01-17 Stack David M (CEO and Chairman) Option Ex 15,000 5.49 82,350
2016-11-15 Scibetta James S (President) Sale 20,000 36.50 730,000
2016-11-15 Scibetta James S (President) Option Ex 20,000 1.61 32,200
2016-11-15 Stack David M (CEO and Chairman) Sale 15,000 37.48 562,275
2016-11-15 Stack David M (CEO and Chairman) Option Ex 15,000 5.49 82,350
2016-10-05 Stack David M (CEO and Chairman) Option Ex 30,000 1.61 48,300
2016-08-15 Scibetta James S (President) Sale 25,000 45.21 1,130,250
2016-08-15 Scibetta James S (President) Option Ex 25,000 1.61 40,250
2016-08-15 Stack David M (CEO and Chairman) Sale 15,000 45.32 679,800
2016-08-15 Stack David M (CEO and Chairman) Option Ex 15,000 5.49 82,350
2016-06-07 Riker Lauren Bullaro (Vice President, Finance) Sale 617 47.90 29,554
2016-06-06 Kronenfeld Mark A. (Director) Sale 900 46.95 42,255
2016-06-06 Riker Lauren Bullaro (Vice President, Finance) Sale 321 47.20 15,150
2016-06-06 Brege Laura (Director) Sale 1,000 46.95 46,950
2016-06-06 Hastings Paul J (Director) Sale 1,136 46.95 53,335
2016-06-06 Williams Kristen Marie (CAO and General Counsel) Sale 600 47.20 28,319
2016-04-15 Stack David M (CEO and Chairman) Sale 25,000 64.30 1,607,375
2016-04-15 Stack David M (CEO and Chairman) Option Ex 25,000 5.49 137,250
2016-02-17 Hastings Paul J (Director) Sale 3,000 60.00 180,000
2016-02-17 Hastings Paul J (Director) Option Ex 3,000 12.39 37,185
2016-01-29 Braunstein Scott (SVP, Strategy & Corp. Dev.) Buy 2,000 58.92 117,840
2016-01-27 Jones James B (SVP & Chief Medical Officer) Buy 500 62.50 31,250
2016-01-15 Stack David M (CEO and Chairman) Sale 15,000 63.57 953,505
2016-01-15 Stack David M (CEO and Chairman) Option Ex 15,000 1.61 24,150
2016-01-12 Jones James B (SVP & Chief Medical Officer) Buy 1,000 66.00 66,000
2016-01-12 Longenecker John P Phd (Director) Buy 300 66.55 19,964
2015-11-20 Hastings Paul J (Director) Sale 3,000 60.00 180,000
2015-11-20 Hastings Paul J (Director) Option Ex 3,000 10.81 32,430
2015-10-15 Stack David M (President, CEO and Chairman) Sale 15,000 37.83 567,450
2015-10-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2015-09-11 Scibetta James S (SVP, Chief Financial Officer) Buy 5,000 61.37 306,850
2015-08-17 Hastings Paul J (Director) Sale 3,000 60.02 180,060
2015-08-17 Hastings Paul J (Director) Option Ex 3,000 10.81 32,430
2015-07-15 Stack David M (President, CEO and Chairman) Sale 15,000 67.78 1,016,700
2015-07-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2015-04-15 Stack David M (President, CEO and Chairman) Sale 25,000 90.50 2,262,475
2015-04-15 Stack David M (President, CEO and Chairman) Option Ex 25,000 1.61 40,250
2015-04-10 Hastings Paul J (Director) Sale 2,500 88.00 220,000
2015-04-10 Hastings Paul J (Director) Option Ex 2,500 13.98 34,950
2015-03-17 Markvicka Taunia (SVP, Chief Commercial Officer) Option Ex 8,349 5.49 45,836
2015-03-16 Riker Lauren Bullaro (Executive Director, Finance) Sale 5,000 95.34 476,700
2015-03-16 Riker Lauren Bullaro (Executive Director, Finance) Option Ex 5,000 10.34 51,700
2015-03-13 Pace Gary W (Director) Buy 1,000 93.83 93,830
2015-03-12 Longenecker John P Phd (Director) Sale 3,000 95.28 285,840
2015-03-12 Longenecker John P Phd (Director) Option Ex 3,000 29.90 89,700
2015-02-06 Scibetta James S (SVP, Chief Financial Officer) Sale 15,000 111.54 1,673,130
2015-02-06 Scibetta James S (SVP, Chief Financial Officer) Option Ex 15,000 1.61 24,150
2015-01-15 Stack David M (President, CEO and Chairman) Sale 15,000 97.92 1,468,755
2015-01-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2015-01-12 Hastings Paul J (Director) Sale 2,500 94.06 235,150
2015-01-12 Hastings Paul J (Director) Option Ex 2,500 13.98 34,950
2014-12-29 Longenecker John P Phd (Director) Sale 1,000 93.32 93,320
2014-12-29 Longenecker John P Phd (Director) Option Ex 1,000 29.90 29,900
2014-12-05 Winger Dennis L (Director) Buy 2,645 94.54 250,058
2014-11-07 Markvicka Taunia (SVP, Chief Commercial Officer) Buy 230 86.62 19,922
2014-11-07 Scibetta James S (SVP, Chief Financial Officer) Sale 15,000 88.13 1,321,980
2014-11-07 Scibetta James S (SVP, Chief Financial Officer) Option Ex 15,000 1.61 24,150
2014-11-03 Kronenfeld Mark A. (Director) Buy 850 90.48 76,908
2014-10-15 Stack David M (President, CEO and Chairman) Sale 15,000 98.88 1,483,170
2014-10-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2014-10-10 Hastings Paul J (Director) Sale 2,500 94.87 237,175
2014-10-10 Hastings Paul J (Director) Option Ex 2,500 13.98 34,950
2014-09-29 Longenecker John P Phd (Director) Sale 1,000 96.40 96,400
2014-09-29 Longenecker John P Phd (Director) Option Ex 1,000 29.90 29,900
2014-08-29 Wicki Andreas Sale 10,481 108.15 1,133,562
2014-08-28 Wicki Andreas Sale 11,013 108.06 1,190,097
2014-08-27 Wicki Andreas Sale 1,606 108.05 173,534
2014-08-26 Wicki Andreas Sale 24,207 108.11 2,617,018
2014-08-25 Wicki Andreas Sale 30,000 108.07 3,241,980
2014-08-11 Wicki Andreas Sale 67,900 101.51 6,892,529
2014-08-08 Wicki Andreas Sale 82,100 101.00 8,292,100
2014-08-08 Scibetta James S (SVP, Chief Financial Officer) Sale 15,000 99.53 1,492,875
2014-08-08 Scibetta James S (SVP, Chief Financial Officer) Option Ex 15,000 1.61 24,150
2014-08-07 Patou Gary (Chief Medical Officer) Sale 20,000 100.26 2,005,200
2014-08-07 Patou Gary (Chief Medical Officer) Option Ex 20,000 7.40 147,960
2014-07-15 Stack David M (President, CEO and Chairman) Sale 15,000 87.19 1,307,805
2014-07-15 Stack David M (President, CEO and Chairman) Option Ex 15,000 1.61 24,150
2014-07-14 Patou Gary (Chief Medical Officer) Sale 29,700 87.25 2,591,176
2014-07-14 Patou Gary (Chief Medical Officer) Option Ex 30,000 5.97 179,100
2014-07-10 Hastings Paul J (Director) Sale 2,500 84.38 210,957
2014-07-10 Hastings Paul J (Director) Option Ex 2,500 13.98 34,950
2014-06-30 Longenecker John P Phd (Director) Sale 1,000 91.60 91,600
2014-06-30 Longenecker John P Phd (Director) Option Ex 1,000 29.90 29,900
2014-06-09 Wicki Andreas Sale 68,000 85.60 5,820,596
2014-06-06 Wicki Andreas Sale 40,200 82.70 3,324,741
2014-06-05 Wicki Andreas Sale 23,200 82.53 1,914,672
2014-06-04 Wicki Andreas Sale 4,500 82.40 370,809
2014-06-03 Wicki Andreas Sale 57,400 80.72 4,633,213
2014-06-02 Wicki Andreas Sale 10,600 80.52 853,501
2014-05-27 Wicki Andreas Sale 64,400 77.93 5,018,756
2014-05-21 Wicki Andreas Sale 3,600 77.80 280,087
2014-05-12 Patou Gary (Chief Medical Officer) Sale 10,000 75.00 750,000
2014-05-12 Patou Gary (Chief Medical Officer) Option Ex 10,000 5.49 54,900
2014-05-09 Brege Laura (Director) Sale 10,000 74.12 741,200
2014-05-09 Brege Laura (Director) Option Ex 10,000 12.39 123,950
2014-05-09 Patou Gary (Chief Medical Officer) Sale 20,000 74.08 1,481,600
2014-05-09 Patou Gary (Chief Medical Officer) Option Ex 20,000 3.55 71,000
2014-05-09 Stack David M (President, CEO and Chairman) Sale 25,000 74.12 1,852,925
2014-05-09 Stack David M (President, CEO and Chairman) Option Ex 25,000 1.61 40,250
2014-05-08 Wicki Andreas Sale 23,220 75.76 1,759,216
2014-05-08 Scibetta James S (SVP, Chief Financial Officer) Sale 15,000 75.11 1,126,605
2014-05-08 Scibetta James S (SVP, Chief Financial Officer) Option Ex 15,000 1.61 24,150
2014-05-07 Wicki Andreas Sale 600 75.64 45,385
2014-05-06 Wicki Andreas Sale 44,180 75.78 3,348,048
2014-03-28 Longenecker John P Phd (Director) Sale 1,000 64.63 64,629
2014-03-28 Longenecker John P Phd (Director) Option Ex 1,000 29.90 29,900
2014-03-06 Wicki Andreas Sale 2,200 80.11 176,244
2014-03-05 Wicki Andreas Sale 22,687 80.16 1,818,657
2013-12-30 Scibetta James S (Chief Financial Officer) Sale 10,000 55.55 555,500
2013-12-30 Scibetta James S (Chief Financial Officer) Option Ex 10,000 1.61 16,100
2013-12-30 Longenecker John P Phd (Director) Sale 2,500 55.55 138,875
2013-12-30 Longenecker John P Phd (Director) Option Ex 2,500 1.61 4,025
2013-12-30 Stack David M (President and CEO) Sale 15,000 55.84 837,555
2013-12-30 Stack David M (President and CEO) Option Ex 15,000 1.61 24,150
2013-11-06 Markvicka Taunia (Vice President, Commercial) Sale 50,000 52.02 2,600,850
2013-11-06 Markvicka Taunia (Vice President, Commercial) Option Ex 50,000 10.81 540,500
2013-10-01 Patou Gary (Chief Medical Officer) Sale 20,000 48.92 978,400
2013-10-01 Patou Gary (Chief Medical Officer) Option Ex 20,000 1.61 32,200
2013-09-30 Scibetta James S (Chief Financial Officer) Sale 10,000 46.74 467,400
2013-09-30 Scibetta James S (Chief Financial Officer) Option Ex 10,000 1.61 16,100
2013-09-30 Longenecker John P Phd (Director) Sale 2,500 46.74 116,850
2013-09-30 Longenecker John P Phd (Director) Option Ex 2,500 1.61 4,025
2013-09-30 Stack David M (President and CEO) Sale 15,000 47.28 709,200
2013-09-30 Stack David M (President and CEO) Option Ex 15,000 1.61 24,150
2013-09-25 Markvicka Taunia (Vice President, Commercial) Sale 10,000 47.00 470,000
2013-09-25 Markvicka Taunia (Vice President, Commercial) Option Ex 10,000 5.49 54,900
2013-09-11 Kronenfeld Mark A. (Director) Buy 1,000 37.01 37,010
2013-09-11 Wicki Andreas Sale 17,783 37.25 662,416
2013-08-14 Markvicka Taunia (Vice President, Commercial) Sale 14,700 37.00 543,900
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of PCRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pacira Pharmaceuticals, Inc. (symbol PCRX, CIK number 1396814) see the Securities and Exchange Commission (SEC) website.